Ticker Details
Tempest Therapeutics, Inc.
IPO Date:	December 7, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 6.03%
Avg Daily Range (30 D):	$0.06 | 5.99%
Avg Daily Range (90 D):	$0.10 | 5.69%

Institutional Daily Volume
Avg Daily Volume:	.08M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	46
Avg Trade Size (Sh.) (30 D):	184
Avg Trade Size (Sh.) (90 D):	176

Institutional Trades
Total Institutional Trades:	58
Avg Institutional Trade:	$1.06M
Avg Institutional Trade (30 D):	$.82M
Avg Institutional Trade (90 D):	$.82M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.29M
Avg Closing Trade (30 D):	$1.31M
Avg Closing Trade (90 D):	$1.31M
Avg Closing Volume:	23.51K

News

Apr 29, 2026 @ 12:00 PM Tempest to Advance Dual-Targeting CAR-T Platform w... Source: Na

Mar 11, 2026 @ 12:00 PM Tempest Announces Partnership for TPST-2003 in Pre... Source: Na

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Globe Newswire

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Tempest Therapeutics

Sep 25, 2025 @ 5:00 PM Advanced Liver Cancer Clinical Trial Pipeline Show... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-6.01	$-2.53	$-.62
Diluted EPS	$-6.01	$-2.53	$-.62
Revenue
Gross Profit
Net Income / Loss	$-43.1M	$-27.7M	$-4.02M
Operating Income / Loss	$-43.36M	$-27.72M	$-4.08M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Jan 30, 2026	2:1
Apr 09, 2025	1:13
Jun 28, 2021	1:15